ClearPoint Neuro Inc (ClearPoint) is a platform neuro company that enables therapy for neuro disorders with pinpoint accuracy. Its items incorporate the clearpoint framework a careful stage, that empowers the conveyance of treatments to treat neurological infections and issues by giving continuous X-ray direction; the smartFlow cannula an X-ray directed medication conveyance framework. These frameworks are utilized for carrying out intrusive procedures on the mind and heart. ClearPoint collaborates with different clinical gadget organizations and scholarly establishments for the turn of events and commercialization of its item stages and center advances. It serves doctors and emergency clinics. ClearPoint is headquartered in Solana Beach, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company ClearPoint Neuro Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company
ClearPoint Neuro Inc Company Overview
ClearPoint Neuro Inc Company Snapshot
ClearPoint Neuro Inc Pipeline Products and Ongoing Clinical Trials Overview
ClearPoint Neuro Inc – Pipeline Analysis Overview
ClearPoint Neuro Inc - Key Facts
ClearPoint Neuro Inc - Major Products and Services
ClearPoint Neuro Inc Pipeline Products by Development Stage
ClearPoint Neuro Inc Ongoing Clinical Trials by Trial Status
Next-Generation Head Fixation Frames Product Overview
Revolution Robotic-Assisted Navigation System
Revolution Robotic-Assisted Navigation System Product Overview
ClearPoint Neuro Inc - Key Competitors
ClearPoint Neuro Inc - Key Employees
ClearPoint Neuro Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
ClearPoint Neuro Inc, Recent Developments
Dec 11, 2023: ClearPoint Neuro Receives Additional 510(K) Clearance For ClearPoint Neuro Navigation System
Jun 29, 2023: Abstract From the SUS Study to Be Presented During the ESSFN Congress in Stockholm in September
May 16, 2023: Two Additional Clearpoint Prism Systems Installed in the U.S.
May 10, 2023: ClearPoint Neuro to present investigational research and showcase novel innovations at the 26th American Society of Gene & Cell Therapy Annual Meeting in Los Angeles
May 02, 2023: CLS Announces Enrollment Completion of Initial Phase of CLS-Sponsored Glioblastoma Laser Ablation Study With the Clearpoint Prism Neuro Laser Therapy System at Skane University Hospital
Apr 20, 2023: ClearPoint Neuro to showcase two novel innovations at AANS 2023: ClearPoint Maestro Brain Model and ClearPoint Prism Neuro Laser Therapy System
Apr 18, 2023: ClearPoint Neuro announces agreement with NE Scientific to integrate gene therapy infusion coverage tool into ClearPoint Maestro Brain Model
Dec 12, 2022: ClearPoint Neuro announces first patient enrolled in glioblastoma trial using ClearPoint Prism Neuro Laser Therapy System at Skane University Hospital in Sweden
Oct 17, 2022: Clinical Laserthermia Systems receives SEK 5.5 million order from ClearPoint Neuro
Sep 23, 2022: ClearPoint Neuro announces FDA clearance for ClearPoint Prism neuro laser therapy system
Table 20: ClearPoint Prism Neuro Laser Therapy System - Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesion Using the Tranberg Thermal Therapy System and Tranberg Thermoguide Workstation
Table 21: ClearTrace Cardiac Intervention System - Product Status
Table 22: ClearTrace Cardiac Intervention System - Product Description
Table 23: Implantable Neural Electrode - Product Status